Clinical Trials Sponsored by MHE Coalition

Total 21224 results

University of British Columbia
MHE Coalition

Completed

The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses

Exostoses, Multiple Hereditary

Canada
University Hospital, Toulouse
The MSA Coalition

Recruiting

Therapeutic Education for MSA Patients and Their Caregivers (ETP@MS)

Multiple System Atrophy

France
RPCR, Inc.
CyberKnife Coalition

Recruiting

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

Ductal Carcinoma in Situ | Invasive Ductal Carcinoma of Female Breast

United States
Cameroon Coalition Against Malaria (CCAM)

Unknown

Mobilization at the Level of Schools on the Behavioral Change in Favor of the Fight Against Malaria in Mbandjock

Malaria

Cameroon
Prosthetic Design & Research
Amputee Coalition

Unknown

Effectiveness of a Peer Visitation Program to Improve Patient Activation and Quality of Life During Amputation Rehabilitation (AC PVP)

Amputation
Cognition Therapeutics

Completed

Ascending Dose Study of CT1812 in Healthy Volunteers

Cognitive Impairment

Australia
Cognition Therapeutics

Completed

Drug Interaction Study of CT1812 in Healthy Volunteers

Healthy Volunteers

United States
The Aurum Institute NPC
Coalition for Epidemic Preparedness Innovations

Recruiting

Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults. (AUR1-8-341)

COVID-19

South Africa
The University of Queensland
Coalition for Epidemic Preparedness Innovations

Completed

A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY ADULTS.

COVID-19

Australia
Cognition Therapeutics

Recruiting

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Age-Related Macular Degeneration

United States
Cognition Therapeutics

Completed

Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers (COG0107)

Alzheimer Disease

United States
Cognition Therapeutics

Completed

Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

United States
Cognition Therapeutics

Completed

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Australia
Novavax
Coalition for Epidemic Preparedness Innovations

Completed

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

COVID-19

United States, Australia
CureVac
Coalition for Epidemic Preparedness Innovations

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | SARS-CoV-2 | Coronavirus

Belgium, Germany
Cognition Pharmaceuticals, LLC

Completed

A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis

Multiple Sclerosis | Cognition Disorders

United States
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Lebanon, Jordan, Kenya
University of Michigan
Coalition for Pulmonary Fibrosis

Completed

Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States
Digital Cognition Technologies

Completed

Evaluation of DCTclock™ as a Cognitive Assessment Aid

Cognitive Function

United States
The University of Queensland
Syneos Health; Coalition for Epidemic Preparedness Innovations

Active, not recruiting

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Covid19 | SARS-CoV2

Australia
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers

Lassa Fever

United States
Coalition for National Trauma Research
Cerus Corporation

Recruiting

Plasma Resuscitation Without Lung Injury (PROPOLIS)

Burns

United States
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana

Lassa Fever

Ghana
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

Coronavirus Infection

United States
The Emmes Company, LLC
Jain Foundation; Coalition to Cure Calpain 3 (C3)

Terminated

Limb-Girdle Video Assessment

Limb-Girdle Muscular Dystrophy ; Subtypes 2A, 2B, and 2I

United States
GlaxoSmithKline
Cambridge Cognition Ltd

Completed

Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children

Cognition

India
Brain and Cognition Discovery Foundation
Takeda; Cognition Kit; Ctrl Group, Ltd

Completed

Validation Study: Mobile DSST on Cognition in Adults With MDD

Major Depressive Episode

Canada
Wendie Berg
PA Breast Cancer Coalition

Active, not recruiting

Screening Contrast-Enhanced Mammography as an Alternative to MRI (SCEMAM)

Breast Cancer

United States
University of North Florida
Northeast Florida Healthy Start Coalition

Completed

Growing Responsible Fathers Descriptive Program Evaluation

Father-Child Relations
Vaxxinity, Inc.
Syneos Health; Coalition for Epidemic Preparedness Innovations

Active, not recruiting

Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

COVID-19 Vaccines

Philippines, United States, Panama
International AIDS Vaccine Initiative
Coalition for Epidemic Preparedness Innovations

Recruiting

A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa

Lassa Fever

Ghana, Liberia, Nigeria
Public Health Vaccines LLC
Coalition for Epidemic Preparedness Innovations

Completed

A Phase 1 Study to Evaluate Safety & Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Nipah Virus Infection

United States
SK Bioscience Co., Ltd.
Coalition for Epidemic Preparedness Innovations

Completed

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)

COVID-19 (Healthy Volunteers)

Korea, Republic of
Medigen Vaccine Biologics Corp.
Coalition for Epidemic Preparedness Innovations

Completed

A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

COVID-19 Vaccine

Taiwan
Oregon Health and Science University
African American Health Coalition

Terminated

Creating African-American Wellness Through Exercise

Depression

United States
Brain and Cognition Discovery Foundation

Enrolling by invitation

Chart Review of Patients Undergoing Ketamine Infusions

Obsessive-Compulsive Disorder | Bipolar Disorder | Post Traumatic Stress Disorder | Major Depressive Disorder

Canada
Brain and Cognition Discovery Foundation

Completed

Vortioxetine for Post-COVID-19 Condition

Cognitive Impairment | Post-COVID-19 Syndrome | Post-COVID-19 Condition

Canada
Brain and Cognition Discovery Foundation

Completed

Pharmacogenetics Associated With IV Ketamine

Treatment Resistant Depression

Canada
Philliber Research & Evaluation
The Office of Adolescent Health, HHS; Northwest Coalition of Adolescent Health

Completed

Replication of the Teen Outreach Program in the Pacific Northwest

Teenage Pregnancy
Public Health Vaccines LLC
Coalition for Epidemic Preparedness Innovations

Recruiting

Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Nipah Virus Infection

United States
Asian Pacific Liver Center at Coalition of Inclusive...

Unknown

TAF Switch Study in Hepatitis B Monoinfection

Hepatitis B
Brain and Cognition Discovery Foundation

Completed

THINC-it Vortioxetine - Sensitivity to Change

Cognitive Change | Major Depressive Disorder

Canada
Brain and Cognition Discovery Foundation

Completed

Evaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity

Obesity | Anhedonia

Canada
Institut Pasteur
Coalition for Epidemic Preparedness Innovations; Themis Bioscience GmbH

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine (COVID-19-101)

COVID-19

Belgium, France
University of Florida
National Institutes of Health (NIH); Dystonia Coalition

Completed

Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia

Cervical Dystonia

United States
International Vaccine Institute
Inovio Pharmaceuticals; Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19

Coronavirus Infection | SARS-CoV 2

Korea, Republic of
SK Bioscience Co., Ltd.
GlaxoSmithKline; Coalition for Epidemic Preparedness Innovations

Active, not recruiting

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)

COVID-19 (Healthy Volunteers)

Korea, Republic of
Applied Cognition
University of Florida Health

Completed

Applied Cognition Benchmarking Study (BRAIN3)

Healthy

United States
Asian Pacific Liver Center at Coalition of Inclusive...
Gilead Sciences

Not yet recruiting

Testing and Epidemiology of Delta Hepatitis

Chronic Hepatitis D Infection With Hepatitis B

United States
Cognition Therapeutics
National Institute on Aging (NIA)

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Mild to Moderate Alzheimer's Disease

United States, Australia, Netherlands, Czechia, Spain

Clinical Trials Sponsored by MHE Coalition

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations